IXCells, Rosebud Partner on Organoids Model for Rare Disease
27 Jan 2026 //
BUSINESSWIRE
iXCells Taps Steve Smith as CEO
13 Jan 2026 //
CONTRACTPHARMA
iXCells Bio to Run First Patient-Led ALS Precision Medicine Pilot
26 Aug 2025 //
PHARMAWEB
iXCells Unveils iPSCore for Human iPSC-Derived Cell Models
11 Jun 2025 //
BUSINESSWIRE
iXCells Bio Announces Grand Opening and 2024 Rare Disease Month Workshop
01 Feb 2024 //
BUSINESSWIRE
iXCells Biotechnologies Strengthens Leadership Team; Welcomes New CEO
18 Jan 2024 //
BUSINESSWIRE
iXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome
16 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support